Notably, the overactivation of PARP-1 is observed in the lesions of neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (5, 6, 7). Here, PARP1 is linked to neurodegenerative disease.